tradingkey.logo
tradingkey.logo
Search

Agios Pharmaceuticals Inc

AGIO
Add to Watchlist
30.020USD
-2.730-8.34%
Close 07-31 16:00ETQuotes delayed by 15 min
1.79BMarket Cap
LossP/E TTM

AGIO Financials

See Agios Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Agios Pharmaceuticals Inc Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
-1.69/-1.67
Revenue / Forecast
44.74M/25.52M
Period
FY2025 Earnings
Revenue(YoY)
54.03M
48.03%
EPS(YoY)
-7.12
-160.04%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
12.45%-1.69
-8.50%-1.69
-9.54%-1.85
-110.69%-1.78
-14.27%-1.93
-7.44%-1.55
1.46%-1.69
1117.27%16.65
-12.27%-1.69
1.34%-1.45
-358.10%-1.72
---1.64
---1.51
---1.47
--0.66
---4.90
----
----
----
----
Revenue
259.25%44.74M
137.75%20.75M
86.09%19.97M
43.69%12.88M
44.57%12.46M
6.56%8.73M
51.06%10.73M
21.15%8.96M
28.35%8.62M
46.00%8.19M
64.80%7.10M
110.44%7.40M
20.24%6.71M
574.16%5.61M
--4.31M
--3.52M
--5.58M
--832.00K
----
----
Net Profit
10.10%-100.70M
-11.00%-99.11M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
-0.61%-96.52M
1137.97%947.91M
-14.69%-96.12M
-0.66%-81.55M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
138.60%36.53M
7.91%-81.75M
-6.48%-91.81M
-105.06%-94.77M
3.10%-94.63M
10.32%-88.77M
Net Margin
74.98%-225.06%
53.31%-477.74%
39.85%-541.09%
-107.59%-803.05%
19.39%-899.40%
-2.75%-1023.25%
33.40%-899.56%
956.75%10574.69%
10.64%-1115.71%
31.06%-995.84%
-259.38%-1350.70%
---1234.27%
---1248.60%
---1444.43%
--847.47%
---2702.19%
----
----
----
----
Gross Margin
8.07%93.30%
6.94%93.64%
2.64%90.59%
-4.71%86.96%
4.46%86.33%
-5.17%87.57%
-3.81%88.26%
-0.20%91.27%
-1.01%82.65%
2.46%92.34%
1.47%91.75%
--91.44%
--83.49%
--90.12%
--90.42%
--87.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.10%
----
----
----
----
Revenue
259.25%44.74M
137.75%20.75M
86.09%19.97M
43.69%12.88M
44.57%12.46M
6.56%8.73M
51.06%10.73M
21.15%8.96M
28.35%8.62M
46.00%8.19M
64.80%7.10M
110.44%7.40M
20.24%6.71M
574.16%5.61M
--4.31M
--3.52M
--5.58M
--832.00K
----
----
Operating profit
12.99%-110.55M
-3.18%-110.03M
2.77%-121.58M
-13.67%-116.87M
-20.07%-127.06M
-15.81%-106.63M
-17.65%-125.04M
-1.90%-102.81M
-12.93%-105.82M
-1.61%-92.07M
-7.16%-106.28M
-10.77%-100.90M
4.04%-93.70M
10.41%-90.61M
5.39%-99.17M
0.07%-91.09M
-7.04%-97.64M
-10.88%-101.14M
-22.85%-104.83M
-13.53%-91.15M
Net Profit
10.10%-100.70M
-11.00%-99.11M
-11.93%-108.04M
-110.91%-103.43M
-16.54%-112.02M
-9.49%-89.29M
-0.61%-96.52M
1137.97%947.91M
-14.69%-96.12M
-0.66%-81.55M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
138.60%36.53M
7.91%-81.75M
-6.48%-91.81M
-105.06%-94.77M
3.10%-94.63M
10.32%-88.77M
Current assets
-29.60%717.67M
-13.81%834.84M
-2.44%942.05M
-3.82%1.03B
61.28%1.02B
45.96%968.62M
15.80%965.60M
52.51%1.07B
-16.52%632.13M
-16.17%663.63M
0.13%833.84M
-10.27%704.35M
-12.96%757.24M
-18.82%791.66M
-21.75%832.77M
-39.86%784.93M
-48.90%870.01M
-58.59%975.14M
67.15%1.06B
95.08%1.31B
Total current liabilities
-0.27%70.22M
12.37%58.84M
1.29%82.21M
-37.42%74.76M
12.41%70.41M
1.31%52.37M
19.43%81.16M
104.45%119.45M
13.59%62.64M
14.58%51.69M
8.50%67.95M
9.01%58.42M
13.94%55.14M
-1.48%45.11M
4.69%62.63M
-7.43%53.60M
-20.20%48.40M
-52.55%45.79M
-36.62%59.83M
-17.02%57.90M
Total assets
-24.66%1.11B
-23.82%1.18B
-22.00%1.30B
-22.66%1.39B
90.31%1.47B
83.06%1.56B
77.48%1.66B
77.89%1.79B
-28.76%773.06M
-26.20%849.71M
-24.35%937.12M
-14.66%1.01B
-13.36%1.09B
-13.82%1.15B
-13.84%1.24B
-23.43%1.18B
-33.19%1.25B
-46.32%1.34B
68.56%1.44B
69.68%1.54B
Total liabilities
-18.96%82.40M
-14.74%75.88M
-14.83%104.11M
-38.61%101.38M
-9.66%101.68M
-15.88%88.99M
-3.06%122.24M
37.13%165.12M
-6.92%112.55M
-7.83%105.79M
-8.56%126.10M
-7.48%120.42M
-5.83%120.92M
-10.62%114.77M
-5.39%137.90M
-11.30%130.15M
-15.96%128.40M
-33.05%128.41M
-67.86%145.76M
-65.72%146.74M
Total equity
-25.08%1.03B
-24.37%1.11B
-22.57%1.19B
-21.05%1.28B
107.35%1.37B
97.13%1.47B
90.00%1.54B
83.42%1.63B
-31.50%660.51M
-28.23%743.92M
-26.33%811.02M
-15.55%886.84M
-14.22%964.24M
-14.16%1.04B
-14.80%1.10B
-24.71%1.05B
-34.72%1.12B
-47.43%1.21B
223.40%1.29B
190.30%1.39B
Net operating income
25.69%-57.31M
-6.67%-118.92M
27.75%-96.21M
-4.67%-88.15M
-6.25%-77.12M
-11.64%-111.49M
-83.71%-133.17M
-36.62%-84.22M
-8.75%-72.59M
-4.92%-99.87M
-9.56%-72.49M
13.61%-61.64M
10.08%-66.75M
2.61%-95.18M
17.29%-66.16M
4.70%-71.35M
-7.57%-74.23M
-8.32%-97.73M
-61.93%-79.99M
-9.76%-74.87M
Net investment
-49.08%40.21M
25.51%141.31M
283.24%90.08M
-61.90%95.56M
112.02%78.97M
-9.61%112.59M
-151.47%-49.16M
537.49%250.79M
-20.97%37.24M
116.27%124.56M
15.14%95.51M
-62.20%39.34M
-43.09%47.13M
316.75%57.60M
187.85%82.95M
144.72%104.07M
127.78%82.81M
-137.35%-26.57M
-232.25%-94.42M
-84.35%-232.73M
Net financing
4744.62%3.15M
28.35%2.08M
-47.19%2.56M
68.18%4.43M
-94.09%65.00K
-72.39%1.62M
471.66%4.84M
40.12%2.64M
363.71%1.10M
137.70%5.86M
3750.00%847.00K
58.55%1.88M
453.73%237.00K
104.22%2.47M
100.12%22.00K
100.47%1.19M
99.99%-67.00K
-83.36%1.21M
-3293.47%-18.59M
-7379.15%-250.99M

FAQs

What is the total revenue of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 54.03M, with a year-on-year change of 36.50M.

What are the current assets of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its current assets were 942.05M, with a year-on-year change of -2.44.

What are the total assets of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its total assets of Agios Pharmaceuticals Inc were 1.30B, with a year-on-year change of -22.00.

What are the total liabilities of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Agios Pharmaceuticals Inc were 104.11M, with a year-on-year change of -14.83.

What is the total equity of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its total equity of Agios Pharmaceuticals Inc was 1.19B, with a year-on-year change of -22.57.

What is the net operating income of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Agios Pharmaceuticals Inc was -472.13M, with a year-on-year change of -10.90.

What is the net investment of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its net investment of Agios Pharmaceuticals Inc was 377.18M, with a year-on-year change of 3.78.

What is the net financing of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its net financing of Agios Pharmaceuticals Inc was 8.68M, with a year-on-year change of -39.93.

What is the Earnings Per Share (EPS) of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -7.12, with a year-on-year change of -160.04.

What is the net income of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its net income was -412.78M, with a year-on-year change of -161.27.

What is the net margin of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -764.01, with a year-on-year change of -141.39.

What is the gross margin of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 88.26, with a year-on-year change of -0.38.

What is the Return on Equity (ROE) of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -30.20, with a year-on-year change of -152.71.

What is the Return on Assets (ROA) of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -27.89, with a year-on-year change of -153.82.

What is the operating profit of Agios Pharmaceuticals Inc?

According to Agios Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -472.13M, with a year-on-year change of -10.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.